DNA synthesis and repair enzyme

“DNA synthesis and repair enzyme” is a broad, non-specific term encompassing multiple families of enzymes responsible for the replication and integrity of the genome. The main classes include DNA polymerases (enzymes that synthesize DNA strands using a DNA template), DNA ligases (seal nicks in the DNA backbone), helicases (unwind DNA), primases, endonucleases, and exonucleases. DNA repair enzymes comprise those involved in direct reversal, base excision repair, nucleotide excision repair, mismatch repair, and recombination repair pathways. Notable individual targets include DNA polymerase beta (Pol β), DNA ligase I, DNA-dependent protein kinase (DNA-PK), and poly(ADP-ribose) polymerase 1 (PARP1). These enzymes maintain genome stability and are essential for cell viability. They are implicated in carcinogenesis, aging, and responses to genotoxic therapy. Many of these enzymes, particularly those with distinct roles in DNA damage repair, are established therapeutic targets in oncology (e.g., PARP inhibitors for cancers with homologous recombination deficiency). However, the entry “DNA synthesis/repair enzymes” is not a single, specific, or canonical molecular target; it is a functional description that groups many distinct and heterogenous enzymes[1][5][8]. Note: - This target entry is **not correct or specific**; it subsumes a broad category that must be broken into precise molecules/elements for structured databases and therapeutic targeting (e.g., “DNA polymerase beta,” “DNA ligase I,” “PARP1”). “DNA synthesis/repair enzymes” should be replaced with specific enzyme names for clarity and proper structuring, as there are numerous unrelated proteins within this group acting in different mechanisms and contexts[1][5][8].

Other names

DNA replication enzymeDNA repair enzymeDNA polymerase (for a subset)DNA ligaseDNA helicaseendonucleaseexcision repair enzyme (for subsets)

Inhibition of DNA polymerase activity to block DNA replication; Inhibition of DNA repair to promote apoptosis in cancer cells; Pyrimidine and purine analogs cause chain termination during DNA synthesis; PARP inhibition prevents repair of single-strand breaks, leading to double-strand breaks